For the quarter ending 2026-03-31, TEM had -$83,587K decrease in cash & cash equivalents over the period. -$81,479K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -125,919 | -54,166 | -79,982 | -42,843 |
| Change in fair value of warrant liability | - | 0 | 0 | 0 |
| Gain on warrant termination | - | 0 | - | - |
| Reversal of warrant contract asset amortization | - | 0 | - | - |
| Stock-based compensation | 52,706 | 45,339 | 33,979 | 22,455 |
| Gain on warrant exercise | - | 0 | 0 | 0 |
| Loss on marketable equity securities | -32,309 | 11,740 | -1,276 | 37,812 |
| Loss on disposal of property and equipment | -334 | -415 | - | - |
| Loss on debt extinguishment | - | 0 | -12,034 | - |
| Deferred income taxes | 0 | -6,449 | 0 | 0 |
| Losses from equity-method investments | -3,086 | -3,149 | 1,518 | -2,100 |
| Change in fair value of contingent consideration | - | 0 | 0 | 0 |
| Amortization of original issue discount | 1,448 | 1,473 | 1,446 | 609 |
| Amortization of deferred financing fees | 86 | 86 | 66 | 175 |
| Amortization of financeright-of-uselease assets | - | 0 | - | - |
| Change in fair value of holdback liability | -1,167 | -1,628 | -21 | 266 |
| Change in fair value of warrant asset | - | 0 | 0 | 0 |
| Amortization of warrant contract asset | - | 0 | 0 | 0 |
| Depreciation and amortization | -26,175 | -26,908 | -27,031 | -28,032 |
| Provision for bad debt expense | 636 | 1,791 | 142 | 309 |
| Provision for obsolete inventory | 225 | 200 | 1,135 | - |
| Non-cashoperating lease costs | 3,502 | 3,688 | 3,293 | 2,484 |
| Minimum accretion expense | 57 | 159 | 1 | -140 |
| Impairment of intangible assets | - | 0 | - | - |
| Pik interest added to principal | 1,674 | 1,698 | 1,682 | 3,883 |
| Accounts receivable | -1,990 | 27,203 | 14,044 | 3,980 |
| Inventory | 332 | -3,168 | 8,511 | -2,885 |
| Prepaid expenses and other current assets | 2,032 | -2,292 | 3,803 | -5,610 |
| Investments and other assets | -433 | 601 | 5,627 | 7,715 |
| Accounts payable | -50,553 | 11,287 | -25,553 | -16,547 |
| Related party asset | - | 0 | 25,000 | - |
| Deferred revenue | -19,297 | -24,358 | -19,438 | 49,213 |
| Deferred other income | -3,989 | -3,989 | -3,989 | -3,989 |
| Accrued data licensing fees | 6 | 764 | 227 | -4,207 |
| Accrued expenses& other | 5,257 | -7,665 | -12,170 | 34,597 |
| Interest payable | 3,677 | 3,918 | 3,166 | 3,614 |
| Operating lease liabilities | -3,577 | -3,796 | -5,210 | -3,249 |
| Net cash used in operating activities | -73,277 | -36,788 | -119,842 | 44,164 |
| Purchases of property and equipment | 8,202 | 4,755 | 6,706 | 7,514 |
| Proceeds from sale of marketable equity securities | 0 | 0 | 0 | 0 |
| Purchases of marketable equity securities | - | 2,740 | 0 | - |
| Business combinations, net of cash acquired | 0 | 1,641 | -5,737 | 0 |
| Investment in joint venture | - | 0 | 0 | - |
| Capitalized software costs | 1,865 | 1,581 | 1,340 | 1,997 |
| Net cash used in investing activities | -10,067 | -10,717 | -2,309 | -9,511 |
| Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions | - | 0 | 0 | 0 |
| Tax withholding related to net share settlement of restricted stock units | - | 0 | 0 | 0 |
| Issuance of series g-4 preferred stock, net of offering costs | - | 0 | - | - |
| Issuance of series g-5 preferred stock | - | 0 | 0 | 0 |
| Principal payments on finance lease liabilities | - | 0 | - | - |
| Dividends paid | - | 0 | 0 | 0 |
| Purchase of treasury stock | - | 3,040 | - | - |
| Payment of deferred offering costs | 45 | 305 | 501 | 0 |
| Payment of indemnity holdback related to acquisition | - | 0 | 0 | 0 |
| G-4 special payment | - | 0 | 0 | - |
| Principal payments on long-term debt | - | 0 | 276,892 | - |
| Proceeds from revolving credit facility, net of original issue discount | 0 | 0 | 0 | 0 |
| Prepayment premium on long-term debt | - | 0 | 7,841 | - |
| Proceeds from long-term debt, net of original issue discount | 0 | 0 | 0 | 0 |
| Purchases of capped call | - | 0 | 41,775 | - |
| Proceeds from convertible senior notes, net of initial purchasers' discount | - | 0 | 726,497 | - |
| Proceeds from issuance of common stock in connection with at-the-market offering, net of commissions | - | 0 | 195,499 | - |
| Payment of deferred financing fees | 226 | 264 | 297 | 0 |
| Net cash provided by financing activities | -271 | -3,609 | 594,690 | 0 |
| Effect of foreign exchange rates on cash | 28 | 16 | -41 | 72 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -83,587 | -51,098 | 472,498 | 34,725 |
| Cash, cash equivalents and restricted cash, beginning of period | 609,451 | 660,549 | 341,835 | - |
| Cash, cash equivalents and restricted cash, end of period | 525,864 | 609,451 | 660,549 | - |
Tempus AI, Inc. (TEM)
Tempus AI, Inc. (TEM)